FDA approves migraine pill as preventative treatment
Migraine treatment Nurtec, developed by US firm Biohaven, is now approved for preventative and acute use.
BY MIKKEL AABENHUS HEMMINGSEN, TRANSLATED BY CATHERINE BRETT
The preventative treatment industry for migraines has gained a new player in the form of US-based firm Biohaven, which can now start competing with companies like Lundbeck, Amgen and Eli Lilly following a recent FDA approval.
Expres2ion CEO Bent U. Frandsen is one of 3,000 volunteers participating in a phase III trial of Bavarian Nordic’s Covid-19 booster candidate. If the vaccine reaches the market, Expres2ion will be entitled to royalties.